These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5476358)

  • 21. Depot fluphenazine in the treatment of psychosis in a community mental health clinic.
    Bucci L; Fuchs M; Simeon J; Fink M
    Dis Nerv Syst; 1970 Sep; 31():Suppl:28-31. PubMed ID: 4920311
    [No Abstract]   [Full Text] [Related]  

  • 22. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 23. Fluphenazine enanthate: a report of a clinical trial in psychotic patients.
    Karkalas Y
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients.
    Bankier RG; Pettit DE; Bergen B
    Dis Nerv Syst; 1968 Jan; 29(1):56-60. PubMed ID: 4865636
    [No Abstract]   [Full Text] [Related]  

  • 25. [Schizophrenia and its treatment].
    Fünfgeld EW; Kulhanek F
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1979; 7(3):169-80. PubMed ID: 382761
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of oral and injectable phenothiazines in treatment of psychotic patients.
    Yorke ET
    Dis Nerv Syst; 1967 Oct; 28(10):667-70. PubMed ID: 4860894
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluphenazine enanthate in a community psychiatric programme.
    Mahy GE
    West Indian Med J; 1975 Mar; 24(1):61-4. PubMed ID: 1136430
    [No Abstract]   [Full Text] [Related]  

  • 28. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion from oral to i.m. fluphenazine not a simple matter.
    Schneiderhan ME; Gross AG; Marken PA; Ruehter VL; Schmidt SL
    Am J Health Syst Pharm; 1995 Dec; 52(24):2826-7. PubMed ID: 8748570
    [No Abstract]   [Full Text] [Related]  

  • 30. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of fluphenazine use since establishment of a psychiatric section].
    Roger BM
    Ann Med Psychol (Paris); 1972 Apr; 1(4):550-5. PubMed ID: 4342755
    [No Abstract]   [Full Text] [Related]  

  • 32. The long-acting phenothiazines.
    Groves JE; Mandel MR
    Arch Gen Psychiatry; 1975 Jul; 32(7):893-900. PubMed ID: 239663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting fluphenazine injections.
    Drug Ther Bull; 1970 Aug; 8(18):69-71. PubMed ID: 5480246
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical evaluation of prolixin enanthate.
    Goldberg HL; DiMascio A; Chaudhary B
    Psychosomatics; 1970; 11(3):173-7. PubMed ID: 5427131
    [No Abstract]   [Full Text] [Related]  

  • 35. Changing from oral to depot fluphenazine.
    Yadalam KG; Simpson GM
    J Clin Psychiatry; 1988 Sep; 49(9):346-8. PubMed ID: 3417620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of TPN-12 Sandoz in schizophrenia].
    Pogorzelski W; Rogiewicz A; Wojdyslawska I
    Psychiatr Pol; 1973; 7(1):65-8. PubMed ID: 4715834
    [No Abstract]   [Full Text] [Related]  

  • 37. A long-term follow-up of fluphenazine enanthate treatment.
    Keskiner A
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):305-13. PubMed ID: 4197255
    [No Abstract]   [Full Text] [Related]  

  • 38. Triiodothyronine and phenothiazines in schizophrenia.
    Wolpert A; Yaryura-Tobias JA; White L; Merlis S
    Dis Nerv Syst; 1969 Jul; 30(7):487-9. PubMed ID: 5810556
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical study.
    Deverteuil R; Lehmann HE; Ban TA; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1971 Feb; 4(2):219-22. PubMed ID: 5550418
    [No Abstract]   [Full Text] [Related]  

  • 40. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.